Startup Celularity Develops Cell Therapy to Fight COVID-19
What really caught my eye here is Celularity’s unique approach. It is applying “natural killer” (NK) cell therapy to the coronavirus...
Bleeding Edge
The Bleeding Edge is the only free newsletter that features investing insights from editor Colin Tedards. Here, Colin will share what he's watching in the market and which stocks you'll want on your radar.
Why 5G Is a Key Part of Trump’s Agenda
Right now, the major wireless network providers are spending billions of dollars to erect America’s powerful 5G networks…
U.S. COVID-19 Cases Will Soon Peak
The number of new confirmed cases in Italy is already on the decline. The U.S. curve is about 10–11 days behind Italy...
COVID-19 Can’t Stop 5G
First, let me start by saying that things are going to get better…
Insights Into the Rate of NYC COVID-19 Hospitalizations
Last night, I was on a call with a pandemic expert from Johns Hopkins. He commented that NYC is unique due to its very high population density...
Total Unemployment Filings Could Reach 20 Million
A month ago, we knew this wave of job losses was coming, but we didn’t know how bad it would be. What a difference just four weeks make...
Johnson & Johnson Pledges $1 Billion to Fight COVID-19
Make no mistake, PR considerations are going into some of these decisions by “Big Pharma”…